In this week’s Expert View, Cem Zorlular, chief executive of Turkish pharmaceutical company Er-Kim Pharmaceuticals, provides an insight into the commercialization of medicines amid challenging political circumstances.

Across the globe, tense relationships between countries are on the rise. The PwC 25th Annual Global CEO Survey showed that 32% of executives cited geopolitical conflict as a top threat to growth, while 71% said it could inhibit their ability…

Read the full article as it appears on The Pharma Letter (subscription required).